So 0.08c instead of 0.1c. 20% discount but at what risk?
It'll be interesting to see how many sh take up the offer.
Note he said the additional funds will go to 'manufacturing deoxymabs'. That's interesting in itself. I suppose they can be used in other applications besides cancer therapy - which of course would need to pass phase 3 first.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.731M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.2¢ | 0.1¢ | $460 | 259.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 204340723 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 33706749 | 25 |
View Market Depth
| Last trade - 10.12am 28/07/2025 (20 minute delay) ? |
| PAB (ASX) Chart |